Tmunity Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Tmunity Therapeutics's estimated annual revenue is currently $2.6M per year.
- Tmunity Therapeutics received $35.0M in venture funding in April 2018.
- Tmunity Therapeutics's estimated revenue per employee is $77,500
- Tmunity Therapeutics's total funding is $230M.
Employee Data
- Tmunity Therapeutics has 33 Employees.
- Tmunity Therapeutics grew their employee count by -41% last year.
Tmunity Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Executive Director, Quality Assurance | Reveal Email/Phone |
2 | Head Strategic Partnerships; Executive Director Corporate Development | Reveal Email/Phone |
3 | Chief Medical Officer | Reveal Email/Phone |
4 | Manager MSAT | Reveal Email/Phone |
5 | Executive Assistant Office Manager | Reveal Email/Phone |
6 | Project Manager | Reveal Email/Phone |
7 | EVP & Chief Business Officer | Reveal Email/Phone |
8 | Associate Process Development Scientist - Engineering | Reveal Email/Phone |
9 | Associate Process Engineer | Reveal Email/Phone |
10 | Clinical Research Associate | Reveal Email/Phone |
Tmunity Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $1.6M | 10 | 0% | N/A | N/A |
#2 | $4M | 26 | 13% | N/A | N/A |
#3 | $0.9M | 6 | -14% | N/A | N/A |
#4 | $1.1M | 7 | 0% | N/A | N/A |
#5 | $10.9M | 70 | 3% | N/A | N/A |
#6 | $0.7M | 9 | 29% | N/A | N/A |
#7 | $4M | 26 | -16% | N/A | N/A |
#8 | $1.7M | 11 | 22% | N/A | N/A |
#9 | $7.6M | 49 | 2% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is Tmunity Therapeutics?
Our vision is to become the leading innovative global life-sciences company that unlocks the potential of T-cell biology and combines it with the power of T-cell engineering excellence to provide cures for patients. Through our model of seamless and rapid integration of research, translational medicine, manufacturing science, clinical development and customer-centric approaches, we will design and deliver enhanced state-of-the-art solutions for patients in a host of disease areas using Chimeric Antigen Receptors (CARs), Gene edited T-Cells, T regulatory cells (Treg), and engineered T Cell Receptors (TCRs)
keywords:N/A
$230M
Total Funding
33
Number of Employees
$2.6M
Revenue (est)
-41%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Tmunity Therapeutics News
So as Nektar Therapeutics prepares for a future without it, ... several blood cancers into solid tumors took a hit last year when Tmunity,...
In addition to ICANS, another known side effect of CAR-T therapies is cytokine release syndrome, which caused setbacks in several clinical...
Tmunity, which is based in Philadelphia, has its own manufacturing operations in East Norriton. Tmunity's founders include June and fellow Penn...
PHILADELPHIA--(BUSINESS WIRE)--Tmunity Therapeutics, in pursuit of its vision to save and improve lives by delivering the full potential of next-generation T-cell immunotherapy, closed a $75 million Series B financing. The financing was led by Andreessen Horowitz (also known as "a16z"), a ventur ...
Tmunity Therapeutics, a Philadelphia, PA-based T-cell immunotherapy company, closed a $75m Series B financing. The round was led by Andreessen Horowitz with participation from a16z’s Cultural Leadership Fund, Westlake Village BioPartners, Gilead Sciences, The University of Pennsylvania, Be The ...
Other Companies in Philadelphia
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $5.4M | 33 | 3% | N/A |
#2 | $3.8M | 33 | N/A | N/A |
#3 | $3.8M | 33 | N/A | N/A |
#4 | $5.4M | 33 | 10% | N/A |
#5 | $6.6M | 33 | 0% | N/A |
Tmunity Therapeutics Funding
| Date | Amount | Round | Lead Investors | Reference |
|---|---|---|---|---|
| 2018-01-24 | $100.0M | A | Multiple | Article |
| 2018-04-20 | $35.0M | A | Kleiner Perkins | Article |